{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:24:15Z","timestamp":1792189455681,"version":"4.4.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,13]]},"DOI":"10.1097\/qad.0b013e328336781d","type":"journal-article","created":{"date-parts":[[2010,3,3]],"date-time":"2010-03-03T01:34:22Z","timestamp":1267580062000},"page":"659-667","source":"Crossref","is-referenced-by-count":20,"title":["N348I in reverse transcriptase provides a genetic pathway for HIV-1 to select thymidine analogue mutations and mutations antagonistic to thymidine analogue mutations"],"prefix":"10.1097","volume":"24","author":[{"given":"Jessica","family":"Radzio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Huey","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Tachedjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sluis-Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(91)81089-Q","article-title":"Factors contributing to the inhibition of HIV reverse transcriptase by chain-terminating nucleotides in vitro and in vivo","volume":"291","author":"Goody","year":"1991","journal-title":"FEBS Lett"},{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.virusres.2008.01.002","article-title":"Mechanisms of inhibition of HIV replication by nonnucleoside reverse transcriptase inhibitors","volume":"134","author":"Sluis-Cremer","year":"2008","journal-title":"Virus Res"},{"key":"R3-5-20210130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.296.7.827","article-title":"Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel","volume":"296","author":"Hammer","year":"2006","journal-title":"JAMA"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1128\/AAC.35.2.322","article-title":"Antihuman immunodeficiency virus synergism by zidovudine (3\u2032-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells","volume":"35","author":"Dornsife","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/infdis\/164.4.646","article-title":"Two-drug combinations of zidovudine, didanosine, and recombinant interferon-alpha A inhibit replication of zidovudine-resistant human immunodeficiency virus type 1 synergistically in vitro","volume":"164","author":"Johnson","year":"1991","journal-title":"J Infect Dis"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/infdis\/169.1.9","article-title":"A randomized pilot study of alternating or simultaneous zidovudine and didanosine therapy in patients with symptomatic human immunodeficiency virus infection","volume":"169","author":"Yarchoan","year":"1994","journal-title":"J Infect Dis"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0006-2952(96)00056-1","article-title":"Favorable interaction of beta-L(-) nucleoside analogues with clinically approved anti-HIV nucleoside analogues for the treatment of human immunodeficiency virus","volume":"51","author":"Bridges","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"13223","DOI":"10.1021\/bi970852k","article-title":"Synergistic inhibition of HIV-1 reverse transcriptase by combinations of chain-terminating nucleotides","volume":"36","author":"Villahermosa","year":"1997","journal-title":"Biochemistry"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1126\/science.1716788","article-title":"Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase","volume":"253","author":"St Clair","year":"1991","journal-title":"Science"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1126\/science.7542804","article-title":"Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy","volume":"269","author":"Larder","year":"1995","journal-title":"Science"},{"key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1086\/514056","article-title":"Lamivudine-resistant human immunodeficiency virus type 1 variants (184V) require multiple amino acid changes to become co-resistant to zidovudine in vivo","volume":"176","author":"Nijhuis","year":"1997","journal-title":"J Infect Dis"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1128\/JVI.74.8.3579-3585.2000","article-title":"The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis","volume":"74","author":"G\u00f6tte","year":"2000","journal-title":"J Virol"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1128\/JVI.76.7.3248-3256.2002","article-title":"The M184V mutation reduces the selective excision of zidovudine 5(-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1","volume":"76","author":"Boyer","year":"2002","journal-title":"J Virol"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1128\/AAC.49.7.2648-2656.2005","article-title":"The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations","volume":"49","author":"Miranda","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R15-5-20210130","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1128\/AAC.49.7.2657-2664.2005","article-title":"Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase","volume":"49","author":"Frankel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R16-5-20210130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1128\/AAC.35.2.305","article-title":"BI-RG-587 is active against zidovudine-resistant human immunodeficiency virus type 1 and synergistic with zidovudine","volume":"35","author":"Richman","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"R17-5-20210130","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1128\/AAC.36.12.2664","article-title":"3\u2032-Azido-3\u2032-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors","volume":"36","author":"Larder","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"40464","DOI":"10.1074\/jbc.M302928200","article-title":"The Y181C substitution in 3\u2032-azido-3\u2032-deoxythymidine-resistant human immunodeficiency virus, type 1, reverse transcriptase suppresses the ATP-mediated repair of the 3\u2032-azido-3\u2032-deoxythymidine 5\u2032-monophosphate-terminated primer","volume":"278","author":"Selmi","year":"2003","journal-title":"J Biol Chem"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1074\/jbc.C300523200","article-title":"Defining a molecular mechanism of synergy between nucleoside and nonnucleoside AIDS drugs","volume":"279","author":"Basavapathruni","year":"2004","journal-title":"J Biol Chem"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/mol.107.038596","article-title":"Efavirenz accelerates HIV-1 reverse transcriptase ribonuclease H cleavage, leading to diminished zidovudine excision","volume":"73","author":"Radzio","year":"2008","journal-title":"Mol Pharmacol"},{"key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1086\/339706","article-title":"Broad nucleoside-analogue resistance implications for human immunodeficiency virus type 1 reverse-transcriptase mutations at codons 44 and 118","volume":"185","author":"Romano","year":"2002","journal-title":"J Infect Dis"},{"key":"R22-5-20210130","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1128\/JVI.72.6.5093-5098.1998","article-title":"A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine","volume":"72","author":"Kemp","year":"1998","journal-title":"J Virol"},{"key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1128\/AAC.46.12.4000-4003.2002","article-title":"Phenotypic and genotypic analysis of biologically cloned human immunodeficiency virus type 1 isolates from patients treated with zidovudine and lamivudine","volume":"46","author":"Stoeckli","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1371\/journal.pmed.0040335","article-title":"N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance","volume":"4","author":"Yap","year":"2007","journal-title":"PLoS Med"},{"key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"13471","DOI":"10.1073\/pnas.95.23.13471","article-title":"Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism","volume":"95","author":"Meyer","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-5-20210130","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1021\/bi034435l","article-title":"Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis","volume":"42","author":"Ray","year":"2003","journal-title":"Biochemistry"},{"key":"R28-5-20210130","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/JVI.75.10.4832-4842.2001","article-title":"Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase","volume":"75","author":"Boyer","year":"2001","journal-title":"J Virol"},{"key":"R29-5-20210130","doi-asserted-by":"crossref","first-page":"22222","DOI":"10.1074\/jbc.M803521200","article-title":"Connection domain mutations N348I and A360V in HIV-1 reverse transcriptase enhance resistance to 3\u2032-azido-3\u2032-deoxythymidine through both RNase H-dependent and -independent mechanisms","volume":"283","author":"Ehteshami","year":"2008","journal-title":"J Biol Chem"},{"key":"R30-5-20210130","doi-asserted-by":"crossref","first-page":"10943","DOI":"10.1073\/pnas.0804660105","article-title":"HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision","volume":"105","author":"Delviks-Frankenberry","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R31-5-20210130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1432-1033.1990.tb15306.x","article-title":"Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography","volume":"187","author":"Le Grice","year":"1990","journal-title":"Eur J Biochem"},{"key":"R32-5-20210130","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0076-6879(95)62015-X","article-title":"Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase","volume":"262","author":"Le Grice","year":"1995","journal-title":"Methods Enzymol"},{"key":"R33-5-20210130","doi-asserted-by":"crossref","first-page":"14020","DOI":"10.1021\/bi8014778","article-title":"Mechanism by which a glutamine to leucine substitution at residue 509 in the ribonuclease H domain of HIV-1 reverse transcriptase confers zidovudine resistance","volume":"47","author":"Brehm","year":"2008","journal-title":"Biochemistry"},{"key":"R34-5-20210130","doi-asserted-by":"crossref","first-page":"29047","DOI":"10.1074\/jbc.M503166200","article-title":"The 3\u2032-azido group is not the primary determinant of 3\u2032-azido-3\u2032-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1","volume":"280","author":"Sluis-Cremer","year":"2005","journal-title":"J Biol Chem"},{"key":"R35-5-20210130","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1021\/bi052362v","article-title":"Modulation of human immunodeficiency virus type 1 synergistic inhibition by reverse transcriptase mutations","volume":"45","author":"Basavapathruni","year":"2006","journal-title":"Biochemistry"},{"key":"R36-5-20210130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/165.1.105","article-title":"Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects","volume":"165","author":"Boucher","year":"1992","journal-title":"J Infect Dis"},{"key":"R37-5-20210130","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1128\/JVI.02203-06","article-title":"Selection of mutations in the connection and RNase H domains of human immunodeficiency virus type 1 reverse transcriptase that increase resistance to 3\u2032-Azido-3\u2032-dideoxythymidine","volume":"81","author":"Brehm","year":"2007","journal-title":"J Virol"},{"key":"R38-5-20210130","first-page":"S159","article-title":"Residue K70 in HIV-1 reverse transcriptase: a crossroad between excision and discrimination mechanisms of NRTI resistance [abstract #143]","volume":"11","author":"Zelina","year":"2006","journal-title":"Antivir Ther"},{"key":"R39-5-20210130","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/JVI.01154-07","article-title":"Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors","volume":"82","author":"Hachiya","year":"2009","journal-title":"J Virol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-201003130-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:18:40Z","timestamp":1786040320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-201003130-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,13]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328336781d","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3,13]]}}}